Clinical Trials Logo

Recurrent Lymphomatoid Granulomatosis clinical trials

View clinical trials related to Recurrent Lymphomatoid Granulomatosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT03038672 Not yet recruiting - Clinical trials for Refractory Diffuse Large B-Cell Lymphoma

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Start date: December 8, 2017
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well nivolumab with or without varlilumab works in treating patients with aggressive B-cell lymphomas that have come back or do not respond to treatment. Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells.